A.R.T. Advisors’s Protalix BioTherapeutics PLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-38,196
| Closed | -$319K | – | 1592 |
|
|
2017
Q2 | $319K | Buy |
38,196
+16,756
| +78% | +$140K | 0.02% | 987 |
|
|
2017
Q1 | $291K | Buy |
+21,440
| New | +$291K | 0.01% | 1014 |
|
|
2016
Q2 | – | Sell |
-2,221
| Closed | -$18K | – | 1573 |
|
|
2016
Q1 | $18K | Sell |
2,221
-5,790
| -72% | -$46.9K | ﹤0.01% | 1320 |
|
|
2015
Q4 | $81K | Buy |
8,011
+5,317
| +197% | +$53.8K | ﹤0.01% | 1349 |
|
|
2015
Q3 | $31K | Hold |
2,694
| – | – | ﹤0.01% | 1305 |
|
|
2015
Q2 | $52K | Sell |
2,694
-240
| -8% | -$4.63K | ﹤0.01% | 1408 |
|
|
2015
Q1 | $52K | Sell |
2,934
-10
| -0.3% | -$177 | ﹤0.01% | 1359 |
|
|
2014
Q4 | $54K | Buy |
2,944
+1,691
| +135% | +$31K | ﹤0.01% | 1341 |
|
|
2014
Q3 | $30K | Buy |
+1,253
| New | +$30K | ﹤0.01% | 1259 |
|
|
2014
Q2 | – | Sell |
-1,700
| Closed | -$77K | – | 1478 |
|
|
2014
Q1 | $77K | Sell |
1,700
-432
| -20% | -$19.6K | ﹤0.01% | 1253 |
|
|
2013
Q4 | $82K | Sell |
2,132
-384
| -15% | -$14.8K | ﹤0.01% | 1204 |
|
|
2013
Q3 | $113K | Sell |
2,516
-1,190
| -32% | -$53.4K | 0.01% | 1207 |
|
|
2013
Q2 | $181K | Buy |
+3,706
| New | +$181K | 0.01% | 1172 |
|